Abbvie reported $9.62B in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US USD 8.76B 123M
Abbvie ABBV:US USD 9.62B 590M
Amgen AMGN:US USD 4.61B 695M
AstraZeneca AZN:LN USD 10.11B 376M
Astrazeneca AZN:US USD 10.11B 376M
Biogen BIIB:US USD 1.84B 650.7M
Biomarin Pharmaceutical BMRN:US USD 562.04M 54.28M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Coherus Biosciences CHRS:US USD 96.84M 29.03M
Eisai 4523:JP JPY 179B 2.46B
Eli Lilly And LLY:US USD 5.47B 200.3M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Gilead Sciences GILD:US USD 5.12B 917M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Horizon Pharma HZNP:US USD 768.1M 3.34M
Infinity Pharmaceuticals INFI:US USD 11.59M 1.11M
Intercept Pharmaceuticals ICPT:US USD 95.24M 84.25M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Medtronic MDT:US USD 6.34B 150M
Merk MRK:US USD 10.32B 624M
Neurocrine Biosciences NBIX:US USD 308.6M 8.5M
Novartis NOVN:VX USD 11.05B 378M
Pacira Pharmaceuticals PCRX:US USD 181.85M 35.67M
Perrigo Ordinary Shares PRGO:US USD 1.12B 57.6M
Pfizer PFE:US USD 19.12B 5.9B
Regeneron Pharmaceuticals REGN:US USD 2.27B 555.1M
Revance Therapeutics RVNC:US USD 194.33M 87.83M
Roche Holding ROG:VX 25.06B 4.31B
Teva Pharmaceutical Industries TEVA:US USD 4.74B 1.56B
Ultragenyx Pharmaceutical RARE:US USD 248.98M 66.79M
United Therapeutics UTHR:US USD 315.9M 114.2M
Vertex Pharmaceuticals VRTX:US USD 1.27B 61.6M
Zoetis ZTS:US USD 1.45B 113M